These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 2031608)

  • 1. Energy content of stools in normal healthy controls and patients with cystic fibrosis.
    Murphy JL; Wootton SA; Bond SA; Jackson AA
    Arch Dis Child; 1991 Apr; 66(4):495-500. PubMed ID: 2031608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipid, nitrogen, water and energy content of a single stool sample in healthy children and children with cystic fibrosis.
    Van den Neucker AM; Forget PP; van Kreel B
    Eur J Pediatr; 2003 Nov; 162(11):764-6. PubMed ID: 12942318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of taurine supplementation on fat and energy absorption in cystic fibrosis.
    De Curtis M; Santamaria F; Ercolini P; Vittoria L; De Ritis G; Garofalo V; Ciccimarra F
    Arch Dis Child; 1992 Sep; 67(9):1082-5. PubMed ID: 1417050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-chain fatty acid absorption in patients with cystic fibrosis.
    Vaisman N; Tabachnik E; Sklan D
    J Pediatr Gastroenterol Nutr; 1992 Aug; 15(2):146-9. PubMed ID: 1403462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maldigestion and malabsorption of 13C labelled tripalmitin in gastrostomy-fed patients with cystic fibrosis.
    Laiho KM; Gavin J; Murphy JL; Connett GJ; Wootton SA
    Clin Nutr; 2004 Jun; 23(3):347-53. PubMed ID: 15158298
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastrointestinal handling of [1-13C]palmitic acid in healthy controls and patients with cystic fibrosis.
    Murphy JL; Jones AE; Stolinski M; Wootton SA
    Arch Dis Child; 1997 May; 76(5):425-7. PubMed ID: 9196358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excessive faecal losses of vitamin A (retinol) in cystic fibrosis.
    Ahmed F; Ellis J; Murphy J; Wootton S; Jackson AA
    Arch Dis Child; 1990 Jun; 65(6):589-93. PubMed ID: 2378514
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of two pancreatin microsphere preparations in cystic fibrosis.
    Elliott RB; Escobar LC; Lees HR; Akroyd RM; Reilly HC
    N Z Med J; 1992 Mar; 105(930):107-8. PubMed ID: 1553114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Energy Balance and Mechanisms of Weight Gain with Ivacaftor Treatment of Cystic Fibrosis Gating Mutations.
    Stallings VA; Sainath N; Oberle M; Bertolaso C; Schall JI
    J Pediatr; 2018 Oct; 201():229-237.e4. PubMed ID: 30029855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Energy and nutrient intakes in cystic fibrosis.
    Buchdahl RM; Fulleylove C; Marchant JL; Warner JO; Brueton MJ
    Arch Dis Child; 1989 Mar; 64(3):373-8. PubMed ID: 2705801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Energy expenditure, nutrition status, and body composition in children with cystic fibrosis.
    Marín VB; Velandia S; Hunter B; Gattas V; Fielbaum O; Herrera O; Díaz E
    Nutrition; 2004 Feb; 20(2):181-6. PubMed ID: 14962683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resting energy expenditure and substrate oxidation rates in cystic fibrosis.
    Bowler IM; Green JH; Wolfe SP; Littlewood JM
    Arch Dis Child; 1993 Jun; 68(6):754-9. PubMed ID: 8333766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of cimetidine and pancreatic enzymes on serum and fecal bile acids and fat absorption in cystic fibrosis.
    Boyle BJ; Long WB; Balistreri WF; Widzer SJ; Huang N
    Gastroenterology; 1980 May; 78(5 Pt 1):950-3. PubMed ID: 7380201
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: a multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study.
    Graff GR; Maguiness K; McNamara J; Morton R; Boyd D; Beckmann K; Bennett D
    Clin Ther; 2010 Jan; 32(1):89-103. PubMed ID: 20171415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variability of fecal energy content measured in healthy women.
    Murphy JL; Wootton SA; Jackson AA
    Am J Clin Nutr; 1993 Aug; 58(2):137-40. PubMed ID: 8338038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic handling of 13C labelled tripalmitin in healthy controls and patients with cystic fibrosis.
    Murphy JL; Laiho KM; Jones AE; Wootton SA
    Arch Dis Child; 1998 Jul; 79(1):44-7. PubMed ID: 9771251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of long-term cimetidine as an adjuvant to pancreatic enzyme therapy in cystic fibrosis.
    Chalmers DM; Brown RC; Miller MG; Clarke PC; Kelleher J; Littlewood JM; Losowsky MS
    Acta Paediatr Scand; 1985 Jan; 74(1):114-7. PubMed ID: 3885675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogenesis of malnutrition in cystic fibrosis, and its treatment.
    Pencharz PB; Durie PR
    Clin Nutr; 2000 Dec; 19(6):387-94. PubMed ID: 11104588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High dose pancreatic enzymes in cystic fibrosis.
    Robinson PJ; Sly PD
    Arch Dis Child; 1990 Mar; 65(3):311-2. PubMed ID: 2334211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring steatorrhoea in cystic fibrosis.
    De Curtis M; Santamaria F; Ercolini P; Sica G; Bianco V; Ciccimarra F
    Eur J Pediatr; 1994 Jun; 153(6):416-8. PubMed ID: 8088296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.